420.23USD+0.74%Mkt Cap: —P/E: 36.801d ago
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromat…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value44.58B $
Revenue (TTM)4.64B $
Gross Profit2.62B $
Net Income (TTM)166.63M $
Revenue/Share62.10 USD
Last Price420.23 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees16.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS9418481035
Valuation
P/E (Trailing)36.80
P/E (Forward)—
PEG—
EV/EBITDA30.70
EV/Revenue9.60
P/S—
P/B2.60
EPS (TTM)11.43
EPS (Forward)—
52W Range
400.2893% of range421.80
52W High421.80 USD
52W Low400.28 USD
Profitability
Gross Margin56.34%
Oper. Margin9.42%
EBITDA Margin31.26%
Profit Margin3.59%
ROE1.92%
ROA3.56%
Growth
Revenue Growth113.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF549.56M $
CapEx (TTM)—
FCF Margin-3.06%
FCF Yield—
Net Debt4.94B $
Net Debt/EBITDA3.40
Balance Sheet
Debt/Equity36.05
Current Ratio1.86
Quick Ratio1.05
Book Value/Sh154.70 USD
Cash/Share5.486 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.75.75M
Float98.07M
Insiders0.10%
Institutions102.19%
Technical
SMA 50325.04 (+29.3%)
SMA 200285.99 (+46.9%)
Beta1.18
S&P 52W Chg20.80%
Avg Vol (30d)142
Avg Vol (10d)3.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—